NewGenIvf Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4.73	5.43	5.14	5.94	4.12
Revenue Growth	-13.01%	5.79%	-13.59%	44.34%	-
Cost of Revenue	3.77	3.61	3.45	4.41	3.09
Gross Profit	0.96	1.83	1.68	1.54	1.02
Selling, General & Admin	11.68	2.99	1.64	1.14	0.83
Operating Expenses	11.68	2.99	1.64	1.14	0.83
Operating Income	-10.73	-1.16	0.04	0.4	0.2
Interest Expense	-0.62	-0.78	-0.05	-0.08	-0.09
Interest & Investment Income	0	0.01	0	0	0
Other Non Operating Income (Expenses)	0.16	0.97	0.11	0.02	0.05
EBT Excluding Unusual Items	-11.18	-0.96	0.11	0.34	0.16
Gain (Loss) on Sale of Investments	-0.7	-	-	-	-
Gain (Loss) on Sale of Assets	-0.05	-	-	-	-
Other Unusual Items	21.65	-	-	-	-
Pretax Income	9.73	-0.96	0.11	0.34	0.16
Income Tax Expense	-	-0.49	-	0.21	0.29
Earnings From Continuing Operations	9.73	-0.47	0.11	0.14	-0.14
Minority Interest in Earnings	0.15	-0.05	0.02	0.32	0.14
Net Income	9.88	-0.52	0.13	0.46	-0
Net Income to Common	9.88	-0.52	0.13	0.46	-0
Net Income Growth	-	-	-71.61%	-	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-11.06	-8.32	-1.84	1.62	1.42
Gross Margin	20.22%	33.62%	32.74%	25.87%	24.88%
Operating Margin	-226.95%	-21.36%	0.82%	6.71%	4.83%
Profit Margin	209.03%	-9.66%	2.54%	7.72%	-0.01%
Free Cash Flow Margin	-234.03%	-153.08%	-35.75%	27.19%	34.39%
EBITDA	-10.54	-1.14	0.07	0.5	0.37
EBITDA Margin	-222.97%	-21.00%	1.43%	8.40%	8.88%
D&A For EBITDA	0.19	0.02	0.03	0.1	0.17
EBIT	-10.73	-1.16	0.04	0.4	0.2
EBIT Margin	-226.95%	-21.36%	0.82%	6.71%	4.83%
Effective Tax Rate	-	-	-	60.51%	188.70%

SEC Filings: 10-K · 10-Q